BPG is committed to discovery and dissemination of knowledge
Review
Copyright: ©Author(s) 2026.
World J Exp Med. Mar 20, 2026; 16(1): 117024
Published online Mar 20, 2026. doi: 10.5493/wjem.v16.i1.117024
Table 2 Summary of endocrinology effect on very low-density lipoprotein
Disorder/syndrome
Impact due to VLDL
Ref.
Cushing syndromeEnhanced production[61]
Exogenous cortisolDecrease in degradation and enhanced adipose lipolysis[62]
AldosteroneStimulation of aldosterone secretion[65-67]
Growth hormone deficiencyEnhanced secretion and decline in clearance[61]
Growth hormone treatmentIncreased adipose lipolysis and increased clearance[61]
HypothyroidismDecreased degradation with enhanced secretion[73,74]
AndrogenAndrogen-deprivation treatment: Enhanced concentration; transgender males with testosterone treatment: Enhanced concentration[80-82]
Polycystic ovary syndromeEnhanced concentration[84]
Estrogen/progesterone therapyEnhanced concentration[85,86]
ProlactinomaUncertain[94-96]


Write to the Help Desk